| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,818 |
3,547 |
$227K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,330 |
4,137 |
$161K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,153 |
1,129 |
$141K |
| 99223 |
Prolong inpt eval add15 m |
818 |
767 |
$84K |
| 96367 |
|
2,619 |
1,397 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
523 |
520 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,831 |
875 |
$20K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
354 |
236 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,018 |
1,026 |
$12K |
| 96523 |
|
635 |
618 |
$11K |
| 96415 |
|
297 |
142 |
$8K |
| 96417 |
|
130 |
61 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
87 |
87 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,811 |
897 |
$3K |
| 99233 |
Prolong inpt eval add15 m |
50 |
27 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,195 |
612 |
$2K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$1K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
157 |
64 |
$1K |
| 96368 |
|
70 |
52 |
$951.06 |
| J1756 |
Injection, iron sucrose, 1 mg |
26 |
12 |
$924.84 |
| 99443 |
|
13 |
13 |
$751.11 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
56 |
40 |
$568.70 |
| J3490 |
Unclassified drugs |
161 |
98 |
$230.34 |
| J3489 |
Injection, zoledronic acid, 1 mg |
13 |
12 |
$176.82 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
20 |
13 |
$148.00 |